Molecular mechanisms of the immunosuppressive action of cyclosporin A.
Resch
K
K
Institute of Molecular Pharmacology, Medical School Hannover, Germany.
Szamel
M
M
D016572:Cyclosporine / Q000493:pharmacokinetics / Q000494:pharmacology*; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism; D004789:Enzyme Activation / Q000187:drug effects; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics / Q000494:pharmacology*; D007376:Interleukin-2 / Q000235:genetics; D050778:NFATC Transcription Factors; D009687:Nuclear Proteins; D019696:Peptidylprolyl Isomerase / Q000378:metabolism; D011493:Protein Kinase C / Q000378:metabolism; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D016559:Tacrolimus / Q000494:pharmacology; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism
D004268:DNA-Binding Proteins; D007166:Immunosuppressive Agents; D007376:Interleukin-2; D050778:NFATC Transcription Factors; D009687:Nuclear Proteins; D014157:Transcription Factors; D016572:Cyclosporine; D011493:Protein Kinase C; D019696:Peptidylprolyl Isomerase; D016559:Tacrolimus